Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Domagala
Jerzy Domagala, Red Bank, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080199186 | Optical Receiver - A receiver for a differentially phase shift keying formatted optical signal, such as an RZ-DPSK formatted optical signal. Dither control loops are provided for controlling path length in a demodulator and/or for controlling the center wavelength of an optical band pass filter. A feedback loop is provided for controlling the gain of a pre-amplifier, and a method of protecting against optical transients by disabling a pre-amplifier is also provided. A preset delay may be provided to compensate for the differential delay in paths associated with the demodulator arms. When the signal is an RZ-DPSK modulated signal, a clock for retiming data from the optical signal may be derived from a signal on the data path. | 08-21-2008 |
| 20080199192 | Optical Receiver - A receiver for a differentially phase shift keying formatted optical signal, such as an RZ-DPSK formatted optical signal. Dither control loops are provided for controlling path length in a demodulator and/or for controlling the center wavelength of an optical band pass filter. A feedback loop is provided for controlling the gain of a pre-amplifier, and a method of protecting against optical transients by disabling a pre-amplifier is also provided. A preset delay may be provided to compensate for the differential delay in paths associated with the demodulator arms. When the signal is an RZ-DPSK modulated signal, a clock for retiming data from the optical signal may be derived from a signal on the data path. | 08-21-2008 |
| 20080310860 | Method and Apparatus for Decision Threshold Control In An Optical Signal Receiver - A method of adjusting a decision threshold in an optical signal receiver. A forward error correction (FEC) decoder provides a feedback signal representative of corrected errors. The decision threshold is adjusted in response to a polarity of the received signal and to balance a number of corrected ones and zeros. | 12-18-2008 |
Jerzy R. Domagala, Red Bank, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090269081 | Soft Decision Threshold Control in a Signal Receiver Using Soft Decision Error Correction - A soft decision threshold control system and method may be used with a forward error correction (FEC) scheme to adjust or tune one or more soft decision thresholds in response to one or more bit value averages for the threshold(s) and in response to a bit error rate (BER). The bit value average for a soft decision threshold generally refers to an average number of binary values (e.g., logic ones and/or zeros) occurring in a bit stream detected using the soft decision threshold. For different BER levels in a particular system, for example, one or more of the soft decision thresholds may have a predetermined bit value average, which has been determined to provide a certain level of performance (e.g., an optimum performance). Thus, one or more of the soft decision thresholds may be adjusted such that the bit value averages for the soft decision thresholds are adjusted as a function of the BER. The settings of the soft decision thresholds may also be adjusted in response to changes in a signal amplitude of the input signal being detected. | 10-29-2009 |
Megan Domagala, Oakville CA
| Patent application number | Description | Published |
|---|---|---|
| 20090132178 | Crystalline enoyl-(acyl-carrier-protein) Reductase from Heliobacter Pylori - The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention. | 05-21-2009 |
Stefan Domagala, Rzaska PL
| Patent application number | Description | Published |
|---|---|---|
| 20080291632 | Inverter casing - The invention relates to an inverter casing, said inverter casing ( | 11-27-2008 |
Teresa A. Domagala, New South Wales AU
| Patent application number | Description | Published |
|---|---|---|
| 20090155267 | MOLECULE AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule which comprises a C-type lectin or an EGF-like domain such as amphiregulin, CD209L, Langerin, L-selectin or chimeric molecules thereof comprising at least a portion of the protein molecule, such as amphiregulin-Fc, CD209L-Fc, Langerin S, Langerin L, Langerin L-FLAG, Langerin-Fc, L-selectin-Fc wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 06-18-2009 |
| 20090175819 | MOLECULE AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule that comprises a dimeric 4-helix bundle, such as IFN-a2B, IFN-b1, IFN-g, IL-10 or its receptor, such as IFNAR2, IL-10Ra or chimeric molecules thereof comprising at least a portion of the protein molecule, such as IFN-a2B-Fc, IFN-b1-Fc, IFN-g-Fc, IFNAR2-Fc, IL-IO-Fc, IL-10Ra-Fc; wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 07-09-2009 |
Teresa A. Domagala, Botany AU
| Patent application number | Description | Published |
|---|---|---|
| 20090136444 | MOLECULE AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the IL-6 protein family such as G-CSF, IL-11, IL-6, LIF or chimeric molecules thereof, comprising at least a portion of the protein molecule; wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 05-28-2009 |
| 20090232808 | MOLECULES AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule in or related to the tumour necrosis factor (TNF) superfamily such as TNF-a, Lymphotoxin-a (LT-a), TNFRI, TNFRII, OX40, BAFF, NGFR, Fas Ligand or chimeric molecules thereof comprising at least a portion of the protein molecule, such as TNF-a-Fc, LT-a-Fc, TNFRI-Fc, TNFRII-Fc, OX40-Fc, BAFF-Fc, NGFR-Fc, Fas Ligand-Fc; wherein the protein or chimeric molecule thereof has a profile of measurable physiochemical parameters, wherein the profile is indicative of, associated with or forms the basis of one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 09-17-2009 |
| 20090311247 | MOLECULES AND CHIMERIC MOLECULES THEREOF - The present invention relates generally to the fields of proteins, diagnostics, therapeutics and nutrition. More particularly, the present invention provides an isolated protein molecule such as EPO, Flt3-Ligand, Flt3, PDGF-B or VEGF-165 or chimeric molecules thereof comprising at least a portion of the protein molecule, wherein the protein or chimeric molecule has a profile of measurable physiochemical parameters which is indicative of, associated with or forms the basis of, one or more pharmacological traits. The present invention further contemplates the use of the isolated protein or chimeric molecule thereof in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications. | 12-17-2009 |
Teresa Anne Domagala, Alexandria AU
| Patent application number | Description | Published |
|---|---|---|
| 20090117134 | Truncated EGF Receptor - The present invention relates to truncated EGF receptor molecules that exhibit increased binding affinities for EGFR ligands such as EGF and TGF1. The present invention also relates to methods of screening for EGF receptor ligands and methods of treatment which involve the use of these molecules. | 05-07-2009 |
Thomas W. Domagala, Cottage Grove, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100315001 | LIGHT EMITTING DIODE DEVICES CONFIGURED AS A REPLACEMENT TO LINEAR FLUORESCENT TUBE DEVICES - The present invention is directed generally to lighting devices, and more particularly to white light LED-based lighting devices configured as a replacement to linear fluorescent tube devices. In a preferred embodiment of the present invention, the substrate may consist of multiple twelve-inch sections each with individual LEDs. In this configuration, 4 such twelve-inch sections may be aligned collinearly to form a 4 foot white light LED device similar to T5, T8, or T12 fluorescent light tubes. | 12-16-2010 |
| 20110062868 | High luminous output LED lighting devices - A white light LED-based lighting device configured for direct replacement of existing incandescent lighting devices is provided. The white light LED-based lighting device comprises a group of solid state light emitting diodes, electronics to activate the light emitting diodes, said solid state light emitters mounted on a planar surface, reflective optics located at the output of the lighting device, the planar surface with solid state light emitters located at the entrance to said reflective optics, and an encapsulating housing configured for direct replacement of existing incandescent lighting devices. | 03-17-2011 |
Tomasz Domagala, Homosassa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20080223812 | Bottled Beverage Plug for Identification - The present invention discloses a reusable bottle stopper and identifier comprising a main body with which fits over the opening of long neck bottle and a sleeve member which fits in the opening of a long neck bottle. The stopper has a pressure release channel that allows pressure to leave the bottle. The stopper also has an area on the outer portion of said main body where an identification means can be placed. This identification method will specify the owner of the drink. This will be especially helpful at crowed bars or social gatherings where drinks are often intermingled. The quick and easy identification of the bottle's owner will help to eliminate confusion or even arguments. This system will also have the added benefit of preventing the spread of germs and disease that can occur when people share drinks. Additionally, the invention will prevent spills because the stopper acts to create a seal and cover the bottle opening. | 09-18-2008 |